Behavidence
Behavidence, founded 2020 in New York, builds a patented AI digital-phenotyping platform that computes daily Mental Health Similarity Scores from passive mobile behavior, serving clinicians, insurers, employers, government organizations, researchers, developers, and consumers via its Care SaaS, consumer app, and SDK.
- Company typePrivate
- Founded2020
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Behavidence does
Behavidence, Inc. is a New York-headquartered, privately held digital health company founded in 2020 (with a UK subsidiary, Behavidence UK, in Leeds) that builds AI-driven digital-phenotyping software for passive, continuous mental-health monitoring. Its core technology, protected by U.S. Patent No. 12,220,237 and validated in peer-reviewed JMIR and PubMed-indexed studies, derives a daily Mental Health Similarity Score (MHSS) for ADHD, Depression, Anxiety, Focus, Worry and Stress from passive mobile-usage telemetry (app switches, time-in-app, inactivity) without tracking content, with a privacy-by-design AAED architecture (Abstraction, Anonymization, Encryption, Distribution) under AES-256 encryption and HIPAA, GDPR and CE compliance.
The company ships this MHSS engine through three product surfaces: (i) the free consumer Behavidence App on iOS and Android, which delivers a daily personal MHSS and journal; (ii) Behavidence Care, a clinician-facing SaaS platform with a clinic-customized branded patient app for remote PHQ-9, GAD-7, ASRS and PSS administration and longitudinal adherence tracking, sold sales-led to clinics, insurers, employers and government organizations via Calendly demos and a 30-day free trial; and (iii) the Behavidence SDK, a plug-and-play integration module for SaaS platforms, clinical-trial sponsors and researchers priced from $3 per user per month. Named enterprise references include the UK NHS, the U.S. Department of Veterans Affairs, Discovery (insurer) and University Hospital Essen.
The business model combines recurring B2B SaaS subscriptions on Behavidence Care with SDK licensing at a disclosed per-seat starting price, while the consumer app is free and serves as a top-of-funnel acquisition channel. Cumulative disclosed funding is approximately $5.6 million across three 2021–2022 rounds (a $4.3M seed in March 2022 led by Welltech Ventures), with "over $1 million in contracts globally" reported as of the seed announcement; revenue is not separately disclosed. The team is roughly 10 people and remains seed-stage with founder-led leadership (Roy Cohen, CEO; Dr. Girish Srinivasan, CTO/CSO; Dr. Janine Ellenberger, CMO).
Behavidence firmographics
Firmographics- Name
- Behavidence
- Legal name
- Behavidence, Inc.
- Website
- https://behavidence.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Behavidence, founded 2020 in New York, builds a patented AI digital-phenotyping platform that computes daily Mental Health Similarity Scores from passive mobile behavior, serving clinicians, insurers, employers, government organizations, researchers, developers, and consumers via its Care SaaS, consumer app, and SDK.
- Ownership category
- akta.pro rank
Behavidence industry classification
Industry- Product category
- Digital Mental Health Analytics
- NAICS
- Software Publishers (5132), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Behavioral Health & Substance Use Remote Monitoring (HLACAFAD)
- akta.pro secondary industries
- Psychiatry & Medication Management Platforms (HLALAEAB), SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)
Keywords
Where Behavidence is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Behavidence business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Behavidence Care SaaS subscriptions (clinics, insurance, employers, government): Recurring B2B SaaS revenue from monthly and yearly organization licenses for Behavidence Care, including a 30-day free trial onboarding funnel; clinic-customized branded mobile app included.
- Behavidence SDK licensing: Per-user/per-month SDK licensing for third-party platforms, researchers and clinical trials; documented starting price of $3 per user per month.
- Consumer Behavidence mobile app: Free direct-to-consumer mobile app on Google Play and Apple App Store that delivers the Mental Health Similarity Score; serves as a top-of-funnel acquisition channel and indirect revenue driver for the B2B products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Behavidence Care for organizations — 30-day free trial, then flexible monthly or yearly licensing |
| Per seat | Monthly | Behavidence SDK — starts at $3 per user / month |
| Freemium | Pay-as-you-go | Behavidence consumer mobile app — free download |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
Behavidence product offering
Product offeringCore offering
Behavidence develops a patented AI-based mental health monitoring platform built around its Mental Health Similarity Score (MHSS). It passively analyzes users' mobile device behavior via a consumer iOS/Android app to generate daily scores for ADHD, Depression, Anxiety, Focus, Worry and Stress, and packages the same engine as a clinician-facing SaaS (Behavidence Care) and an embeddable SDK for third-party platforms and clinical trials.
Product overview
Behavidence offers a unified platform-plus-modules architecture centered on its patented Mental Health Similarity Score (MHSS) engine (Patent No. 12,220,237). The consumer-facing Behavidence App (iOS/Android) generates the daily MHSS passively from mobile behavior; the clinician-facing Behavidence Care SaaS platform (care.behavidence.com) layers a remote-monitoring dashboard, customizable clinic-branded patient app, and standardized questionnaire administration (PHQ-9, GAD-7, ASRS, PSS) on top of the same MHSS; and the Behavidence SDK exposes those capabilities to third-party researchers, innovators, and SaaS companies as an embeddable integration module. Together, these three product surfaces share one underlying AI/digital-phenotyping core, allowing Behavidence to serve personal users, providers/clinics, employers, insurers, clinical-trial sponsors, and developer partners from a single technology base.
Differentiator
Problem solved
Functional benefit
Brands
- Behavidence Care: Clinician-facing platform for AI-based remote patient mental health monitoring, patient adherence, and standardized questionnaire delivery (PHQ-9, GAD-7, ASRS).
Products and services
- Behavidence App (Consumer Mobile App)
Quantifiable outcome
- Up to 80% accuracy in detecting mental health conditions
- +4 more outcomes
Companies that use Behavidence
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles6 records
Behavidence technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability7 records
Feature5 records
Behavidence partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor (earned-media channel), core (infrastructure backbone) and core (primary consumer distribution channel).
- Forbes (Forbes Technology Council)minor (earned-media channel)Behavidence features a Forbes Technology Council article ('How Technology Is Revolutionizing Mental Health', 2020) on its 'As seen on' media strip on the website and Behavidence Care landing pages. Acts as a third-party editorial endorsement supporting marketing and brand visibility.
- Amazon Web Services (AWS)core (infrastructure backbone)Behavidence states on its Employers page that it delivers 'regular, accurate reporting and data via encrypted AWS servers.' AWS is used as the underlying cloud infrastructure for the Behavidence platform and employee reporting.
- Google Play Storecore (primary consumer distribution channel)Behavidence distributes its Android mobile app (package com.cohen.behavidence) via the Google Play Store, with download links embedded across the company website, blog posts and Behavidence Care landing pages.
- Apple App Storecore (primary consumer distribution channel)Behavidence distributes its iOS mobile app (Apple App Store ID 1600102496) via the Apple App Store, with download links embedded across the company website, blog posts and Behavidence Care landing pages.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Behavidence competitors and assessment
Company assessmentDirect peers
- Kintsugi: Digital mental-health AI company that uses passive voice biomarkers (rather than phone-usage telemetry) to score depression and anxiety. Direct comparable to Behavidence's MHSS approach: passive, AI-derived mental-health scores integrated into payer and clinical workflows.
- Sonde Health: Voice-based mental and respiratory health biomarker platform that uses short voice samples to derive health scores. Highly comparable to Behavidence in modality (passive AI-derived mental-health scoring), enterprise GTM into insurers and employers, and clinical-validation story.
- Woebot Health: AI-driven mental-health intervention platform that combines conversational AI with measurement-based care and remote monitoring. Comparable to Behavidence in its use of AI to augment clinician workflow and its focus on depression/anxiety outcomes, though input modality is chat rather than passive telemetry.
- Ellipsis Health: AI mental-health biomarker company using voice analysis to detect depression and anxiety for payers, providers and employers. Closely comparable business model and customer set to Behavidence Care (insurers, health systems), differentiated only by voice vs. phone-usage input.
Broad incumbents
- Headspace Health: Large consumer and employer mental-health platform formed by the Headspace and Ginger merger, offering therapy, coaching and self-guided content. Broad incumbent competing for the same employer and payer mental-health budgets as Behavidence Care, but with a very different modality.
- Lyra Health: Enterprise mental-health benefits platform serving large employers and health plans with therapy, coaching and digital tools. Comparable to Behavidence's employer and insurer GTM, but Lyra is a scaled incumbent with a network-of-clinicians model rather than passive AI scoring.
- Spring Health: Global employer and health-plan mental-health benefits provider combining AI-driven matching with therapy and coaching. Comparable buyer (employer, payer) and overlap with Behavidence's employer value proposition; significantly larger scale and broader service portfolio.
- Calm: Consumer mental-wellness and meditation app with a large employer/B2B channel. Comparable to Behavidence's consumer and employer mental-wellness play, but built on self-guided content rather than passive digital-phenotyping AI.
- BetterHelp: Largest direct-to-consumer online therapy platform (Teladoc-owned), addressing the same end user need (accessible mental-health support) as Behavidence's consumer app and Behavidence Care clinician offering, but via human therapists rather than AI scoring.
- Cerebral: Telehealth provider focused on ADHD, anxiety and depression treatment with subscription medication management. Closely overlaps with Behavidence's ADHD/depression/anxiety conditions and clinician/insurer GTM, but operates a prescribing and pharmacy model rather than passive AI monitoring.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Behavidence social profiles
Digital presenceBehavidence compliance and trust
Trust signalCompliance4 records
Behavidence financial estimates
Financial estimateRevenue estimate
Valuation estimate
Behavidence leadership team
Management profileNumber of profiles
Profiles11 records
Behavidence subsidiaries and ownership
Company hierarchySubsidiaries1 record
Behavidence funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Behavidence M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Behavidence
What does Behavidence do?
Behavidence develops a patented AI-based mental health monitoring platform built around its Mental Health Similarity Score (MHSS). It passively analyzes users' mobile device behavior via a consumer iOS/Android app to generate daily scores for ADHD, Depression, Anxiety, Focus, Worry and Stress, and packages the same engine as a clinician-facing SaaS (Behavidence Care) and an embeddable SDK for third-party platforms and clinical trials.
Is Behavidence a public or private company?
Behavidence is a private company. It is classified as venture growth investor backed and is currently operating.
When was Behavidence founded?
Behavidence was founded in 2020. It employs 1 to 10 people.
Where is Behavidence based?
Behavidence is headquartered in New York, United States, in the North America region.
How does Behavidence make money?
Three revenue lines are on record. Behavidence Care SaaS subscriptions (clinics, insurance, employers, government) is the primary driver. The others are behavidence SDK licensing and consumer Behavidence mobile app.
Who are Behavidence's main competitors?
Direct peers on record are Kintsugi, Sonde Health, Woebot Health and Ellipsis Health. Broad incumbents are Headspace Health, Lyra Health, Spring Health, Calm, BetterHelp and Cerebral.
Does Behavidence have an API?
Yes. Behavidence offers an embeddable SDK (Software Development Kit) rather than a traditional REST/GraphQL API. The SDK enables third-party platforms, researchers, innovators, and SaaS companies to plug in, calculate, and store the Mental Health Similarity Score (MHSS). Functionalities include: anonymous user sign-up & in, collect & upload data usage, similarity score retraction, standardized clinical & research questionnaire integration, sensor data upload & handling, and journal entry creation. SDK is fully customizable and designed for science, clinical trials, and product integrations. Cost starts at $3 per month per user. Documentation is available upon request via [email protected]. Developer documentation is at www.behavidence.com/partners.
What industry is Behavidence in?
Behavidence's product category is Digital Mental Health Analytics. Its primary akta.pro industry code is HLACAFAD, Behavioral Health & Substance Use Remote Monitoring, with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 5132 and its SIC code is 7372.